Zewei Lin
Overview
Explore the profile of Zewei Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin Z, Cai C, Zhang Y, Zhu X, Peng F, Guo R, et al.
Environ Sci Technol
. 2025 Mar;
PMID: 40042279
Provincial inherent heterogeneity in resource endowment, steel demand, and managerial guidance poses not only challenges but also chances to the decarbonization of China's iron and steel industry (ISI). Previous studies...
2.
Lin Z, Liu J
Mol Med Rep
. 2024 Nov;
31(2).
PMID: 39575490
Following the publication of this paper, and subsequently to the publication of a corrigendum (DOI: 10.3892/mmr.2022.12912) that was intended to address the issue of a pair of incorrectly written primer...
3.
Peng Z, Tan X, Xiong P, Ren Q, Sun D, Lin Z
Radiol Case Rep
. 2024 May;
19(8):3258-3262.
PMID: 38812594
infections persist globally among humans. These pathogens mainly inhabit the intrahepatic biliary system. Most individuals with clonorchiasis exhibit mild symptoms. The absence of distinctive symptoms often results in delayed diagnosis...
4.
Chen E, Zou Z, Wang R, Liu J, Peng Z, Gan Z, et al.
Front Immunol
. 2024 May;
15:1244392.
PMID: 38694506
Objective: Significant advancements have been made in hepatocellular carcinoma (HCC) therapeutics, such as immunotherapy for treating patients with HCC. However, there is a lack of reliable biomarkers for predicting the...
5.
Chen E, Mo Y, Yi J, Liu J, Luo T, Li Z, et al.
Aging (Albany NY)
. 2023 Aug;
15(16):7933-7955.
PMID: 37589508
Tumor oncogenesis, cancer metastasis, and immune evasion were substantially impacted by the mammalian target of the rapamycin complex 1 (mTORC1) pathway. However, in hepatocellular carcinoma (HCC), no mTORC1 signaling-based gene...
6.
Chen E, He Y, Jiang J, Yi J, Zou Z, Song Q, et al.
Exp Hematol Oncol
. 2023 Jan;
12(1):9.
PMID: 36639822
Background: Hepatocellular carcinoma (HCC) is one of the most lethal malignant tumors. Cell division cycle associated 8 (CDCA8) is an important multifactorial regulator in cancers. However, its up and downstream...
7.
Lin Z, Liu J
Mol Med Rep
. 2022 Dec;
27(2).
PMID: 36484391
Following the publication of this article, an interested reader drew to the authors' attention that the primer sequences written for lncRNA DQ786243 and miR‑15b‑5p on p. 2 in the study...
8.
Liu D, Zhu X, Greenwell B, Lin Z
Br J Math Stat Psychol
. 2022 Oct;
76(1):192-210.
PMID: 36250345
Probit models are used extensively for inferential purposes in the social sciences as discrete data are prevalent in a vast body of social studies. Among many accompanying model inference problems,...
9.
Chen E, Yi J, Jiang J, Zou Z, Mo Y, Ren Q, et al.
BMC Cancer
. 2022 Oct;
22(1):1037.
PMID: 36195833
Background: Fatty acid (FA) metabolism is considered the emerging cause of tumor development and metastasis, driving poor prognosis. Long non-coding RNAs (lncRNAs) are closely related to cancer progression and play...
10.
Su Y, Kang Y, Yi J, Lin Q, Zhang C, Lin Z, et al.
Evid Based Complement Alternat Med
. 2022 Jul;
2022:2122563.
PMID: 35795282
Nonalcoholic fatty liver disease (NAFLD) is the most common metabolic liver disease globally, and the incidence of NAFLD has been increasing rapidly year by year. Currently, there is no effective...